von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome

Thromb Haemost. 2001 Jun;85(6):975-8.

Abstract

A deficiency of von Willebrand factor (vWF)-cleaving protease, either due to a congenital deficiency or to the presence of a protease inhibitor of vWF-cleaving protease has been associated with thrombotic thrombocytopenic purpura (TTP). We have studied vWF-cleaving protease in diarrhoea-associated haemolytic uraemic syndrome (D+ HUS), which shares clinical features with TTP. 29 children with acute D+ HUS and 13 control children were studied. vWF-cleaving protease activity was normal (range 50-150%) in 39 of 42 plasma samples. Levels of protease activity between 25 and 50% were noted in plasma from two D+ HUS patients. One D+HUS patient, who had clinical features of TTP, had a vWF-cleaving protease inhibitor producing a severe deficiency of vWF-cleaving protease. Thus a deficiency of vWF-cleaving protease appears to be atypical in D+HUS. The detection of a vWF-cleaving protease inhibitor in one patient suggests it may be associated with infection such as E. coli O157.

MeSH terms

  • ADAM Proteins
  • ADAMTS13 Protein
  • Adolescent
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Diarrhea / enzymology*
  • Diarrhea / etiology
  • Diarrhea / microbiology
  • Escherichia coli Infections / blood
  • Hemolytic-Uremic Syndrome / complications
  • Hemolytic-Uremic Syndrome / enzymology*
  • Hemolytic-Uremic Syndrome / etiology
  • Hemolytic-Uremic Syndrome / microbiology
  • Humans
  • Infant
  • Metalloendopeptidases / antagonists & inhibitors
  • Metalloendopeptidases / blood*
  • Metalloendopeptidases / deficiency
  • Protease Inhibitors / adverse effects
  • Protease Inhibitors / blood
  • Purpura, Thrombocytopenic / enzymology
  • Purpura, Thrombocytopenic / etiology

Substances

  • Protease Inhibitors
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAMTS13 Protein
  • ADAMTS13 protein, human